Report overview
The global Pet Antibiotic market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Pet antibiotics are medications prescribed by veterinarians to treat bacterial infections in various types of pets, including dogs, cats, and other animals. These antibiotics are similar to those used in humans but are specifically formulated and dosed for animals. Just like humans, pets can develop bacterial infections that can lead to various health issues if left untreated. Pet antibiotics help combat these infections and promote the well-being of the animals.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly �6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 496%.
We have surveyed the Pet Antibiotic manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Pet Antibiotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Antibiotic. This report contains market size and forecasts of Pet Antibiotic in global, including the following market information:
Global Pet Antibiotic market revenue, 2020-2025, 2026-2032, ($ millions)
Global Pet Antibiotic market sales, 2020-2025, 2026-2032, (K Units)
Global top five Pet Antibiotic companies in 2024 (%)
Total Market by Segment:
Global Pet Antibiotic market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Pet Antibiotic market segment percentages, by Type, 2024 (%)
Oral
Injection
Others
Global Pet Antibiotic market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Pet Antibiotic market segment percentages, by Application, 2024 (%)
Dogs
Cats
Others
Global Pet Antibiotic market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Pet Antibiotic market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Antibiotic revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Pet Antibiotic revenues share in global market, 2024 (%)
Key companies Pet Antibiotic sales in global market, 2020-2025 (estimated), (K Units)
Key companies Pet Antibiotic sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Elanco
Zoetis
Merck Animal Health
Merial
Bayer HealthCare
Boehringer Ingelheim GmbH
Ceva Sant� Animale
Virbac Group
HealthforAnimals
Cymedica
Dechra
Jinhe Biotechnology
Orion Corporation
Phibro Animal Health Corporation
Vetoquinol
Virbac
Zydus
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Antibiotic, market overview.
Chapter 2: Global Pet Antibiotic market size in revenue and volume.
Chapter 3: Detailed analysis of Pet Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Antibiotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pet Antibiotic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
